NCT01391260 - Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2017

Conditions

Non-small Cell Lung Cancer

Interventions

OTHER

Gefitinib

Radiation Therapy: 3D-CRT/IMRT 95%PTV 60-66Gy, 1.8-2.0Gy/f,5f/w; Gefitinib: 250 mg, Qd, p.o;

Trial Locations (6)

RECRUITING

307 Hosptial of PLA, Beijing

RECRUITING

Beijing Cancer Hospital, Beijing

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

RECRUITING

Chinese Academy of Medical Sciences Cancer Hospital, Beijing

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

RECRUITING

Renmin Hospital of Wuhan University, Hubei General Hospital, Wuhan